Clinical trials
Observational Metabolic Syndrome trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Not yet recruiting | 7 |
| Unknown status | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recep Tayyip Erdogan University Training and Research Hospital | 3 |
| Ankara University | 2 |
| Kayseri City Hospital | 2 |
| Yaşar Bayındır, MD | 2 |
| Abant Izzet Baysal University | 1 |
| Abdi Ibrahim Ilac San. ve Tic A.S. | 1 |
| Antalya Training and Research Hospital | 1 |
| Ataturk Training and Research Hospital | 1 |
| Başakşehir Çam & Sakura City Hospital | 1 |
| Elif Akbas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 32 |
| Fatty Liver | 4 |
| Inflammation | 4 |
| Obesity | 4 |
| Periodontitis | 4 |
| Polycystic Ovary Syndrome | 3 |
| Insulin Resistance | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Overweight | 2 |
| Pediatric Obesity | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.